Isometheptene

Summary

Isometheptene (CHEMBL1697841) is an approved small molecule (ATC A03AX10); indicated across 1 condition.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: A03AX10
• Indications: 1 condition
• Chemistry: 141.25 Da · C9H19N

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1697841
Name	Isometheptene
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	22297
ATC	A03AX10
Molecular formula	C9H19N
Molecular weight	141.25
InChIKey	XVQUOJBERHHONY-UHFFFAOYSA-N

SMILES: CC(CCC=C(C)C)NC

IUPAC name: N,6-dimethylhept-5-en-2-amine

Also known as: Isometepteno, Isometheptene, Isonyl, Octanil, Octin, ISOMETHEPTENE, ISOMETHEPTENE-MUCATE, isometheptene-mucate, isometheptene

Parent form; salt/anhydrous children: CHEMBL1327133, CHEMBL2105026, CHEMBL2355839, CHEMBL4303692

Patent coverage: 478 distinct patent families (1,660 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

1 indication record carries no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No CPIC/DPWG dosing guideline or drug-level clinical/variant annotations in PharmGKB for this molecule.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).